(Q38859455)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27278127%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

review article

1 reference

title

Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27278127%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27278127%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

S Chinnaswamy

series ordinal

1

1 reference

7 September 2017

9 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27278127%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27278127%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27278127%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27278127%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

265-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27278127%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gene.2016.24

13 March 2020

exact match

0 references

cites work

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon type I gene expression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Guarding the frontiers: the biology of type III interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IFN-λ4: the paradoxical new member of the interferon lambda family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Innate immunity: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Pathogen recognition and inflammatory signaling in innate immune defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Innate immunity to virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Intestinal epithelial cells: regulators of barrier function and immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Innate lymphoid cells in the initiation, regulation and resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

The biology of innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

The 3 major types of innate and adaptive cell-mediated effector immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Human innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Regulation of the adaptive immune system by innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon-λ: Immune Functions at Barrier Surfaces and Beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon lambda-2 levels in sputum of patients with pulmonary Mycobacterium tuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Influenza virus activation of the interferon system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Impact and regulation of lambda interferon response in human metapneumovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon-λ in the context of viral infections: production, response and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B gene polymorphisms and Th1/Th2 cytokine levels might be associated with HTLV-associated arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Paradoxical expression of IL-28B mRNA in peripheral blood in human T-cell leukemia virus type-1 mono-infection and co-infection with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Absence of association of IFNL3/IL28B rs 12979860 and IFNL4 ss 469415590 polymorphisms with the neurological status of HTLV-1 Afro-Caribbean subjects in Martinique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Regulation of hepatic innate immunity by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

One more piece in the interleukin 28B gene puzzle? The case of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interleukin 28B genetic polymorphism and hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Effects of polymorphisms in interferon λ 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Hepatitis C infection in HIV-1 natural viral suppressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Hepatitis C virus replication in Caucasian HIV controllers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B genotype does not correlate with HIV control in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B single-nucleotide polymorphism rs12979860 is associated with spontaneous HIV control in white subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Genetic variations in IL28B and allergic disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Anti-viral agents: potential utility in exacerbations of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL-28B is a key regulator of B- and T-cell vaccine responses against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Mechanisms of type III interferon expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon induction and function at the mucosal surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Roles for Transcription Factors Sp1, NF-κB, IRF3, and IRF7 in Expression of the Human IFNL4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

A single nucleotide polymorphism associated with hepatitis C virus infections located in the distal region of the IL28B promoter influences NF-κB-mediated gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Genetic variation of the IL-28B promoter affecting gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

Reply to: “IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients”

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2016.24

IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27278127

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nucleic Acid Sensors Involved in the Recognition of HBV in the Liver-Specific in vivo Transfection Mouse Models-Pattern Recognition Receptors and Sensors for HBV

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27278127

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27278127